The impact of pediatric influenza and COVID-19 hospitalization on parental attitudes toward vaccination Authors: Piotr Rzymski, Barbara Szczepańska, Zuzanna Wasielewska, Małgorzata Pawłowska, Kamila Cywińska, Jan Świerczynski, Anna Dobrzeniecka, Ilona Małecka, Barbara Poniedziałek, Robert Flisiak, Dorota Zarębska-Michaluk Published: 2026 ABSTRACT ABSTRACTHospitalization for vaccine-preventable infections may influence parental vaccination attitudes, but comparative data for influenza and COVID-19 are limited. We conducted a multicenter observational study of unvaccinated children hospitalized with influenza or COVID-19 in Poland. We collected clinical data and parental survey data assessing vaccination regret, future vaccination intentions, willingness to encourage others, interest in vaccination reminders, reasons for non-vaccination, and sources of influence. Parents of influenza-hospitalized children reported greater regret over non-vaccination (62.5% [45/72] vs. 23.8% [15/63]), higher intention to vaccinate in the next season (58.3% [42/72] vs. 15.9% [10/63]), and willingness to encourage other parents to vaccinate (66.7% [48/72] vs. 36.5% [23/63]) than parents of COVID-19-hospitalized children. Multivariate analysis showed influenza hospitalization independently associated with parental regret (OR = 5.5, 95% CI: 2.2–14.0), intention to encourage others to vaccinate children (OR = 3.9, 95% CI: 1.6–9.7), and willingness to vaccinate next season (OR = 9.3, 95% CI: 3.3–26.7), but not interest in receiving vaccination reminder. In the COVID-19 group, more parents wanted vaccination reminders than planned vaccination (41.3% [26/63] vs. 15.9% [10/63]), suggesting openness to further engagement. In this group, regret and vaccination willingness were associated with comorbidities, rural residence, longer hospital stay, and higher C-reactive protein levels. In the influenza cohort, pneumonia was associated with changes in vaccination attitudes. Vaccine refusal was mainly driven by safety and effectiveness concerns for COVID-19 and disease trivialization for influenza. Pediatric influenza hospitalization may provide an opportunity to improve parental vaccination attitudes in the investigated sociocultural context, warranting further studies on targeted post-hospitalization interventions.KEYWORDS: Disease prevention, vaccine hesitancy, vaccine acceptance, respiratory infections, pediatric population Introduction Respiratory viral infections remain a leading cause of morbidity and hospitalization in children worldwide. Influenza and COVID-19 contribute substantially to this burden. Beyond direct health effects, these infections are associated with parental anxiety, school absenteeism, and economic costs.1,2 Vaccination is the most effective preventive measure for both influenza and COVID-19.3 The World Health Organization (WHO) and the European Center for Disease Prevention and Control (ECDC) recommend seasonal influenza vaccination for all children aged ≥6 months,4 while COVID-19 vaccination is advised for eligible pediatric populations, particularly those at increased risk of severe disease.5,6 Despite these recommendations, pediatric vaccine uptake remains suboptimal in many regions, including developed countries.7–9 The COVID-19 pandemic reshaped public perceptions of infectious diseases and vaccination, increasing awareness of disease severity while simultaneously amplifying misinformation, political polarization, and distrust in public health institutions.10,11 These opposing forces produced heterogeneous outcomes: in some populations, willingness to vaccinate against respiratory infections increased,12 whereas in others, pandemic fatigue and skepticism fueled broader vaccine hesitancy.13–15 The pandemic also blurred distinctions between vaccine-preventable diseases, leading parents to compare influenza and COVID-19 in terms of severity, transmissibility, and vaccination necessity.16 Parental attitudes are central to childhood vaccine acceptance. Studies consistently show that beliefs about disease severity, vaccine efficacy, and safety strongly influence vaccination decisions. Common barriers include the perception that influenza or COVID-19 is mild in children, concerns about vaccine safety, skepticism toward pharmaceutical companies or governmental recommendations, and the impact of misinformation spread through social media. Conversely, trust in healthcare professionals and personal experience with severe disease tend to increase vaccine acceptance.17,18 However, hospitalization for a vaccine-preventable respiratory infection can be a particularly influential event. Such an experience may act as a “teachable moment,” potentially prompting parents to reconsider prior beliefs and eventually adopt preventive measures. Yet, evidence on whether hospitalization consistently translates into higher vaccine uptake is inconclusive, as emotional distress or lingering distrust may sometimes reinforce hesitancy.19 In Poland, low pediatric vaccine coverage has been linked to limited institutional trust, historical skepticism toward authorities, and insufficient science communication.20–22 Research exploring how experiences during the COVID-19 pandemic have shaped parental perceptions of both COVID-19 and influenza vaccination in Poland is currently lacking. This knowledge gap is particularly important given the country’s very low annual influenza vaccination rates among children and COVID-19 coverage that remains below the European Union average,23 a context that may differ substantially from other healthcare and sociocultural settings. Moreover, no study has directly compared parental attitudes after pediatric hospitalization for influenza versus COVID-19. Therefore, this study aimed to evaluate parental attitudes toward influenza and COVID-19 vaccination following pediatric hospitalization of unvaccinated children for either infection in Poland. We also examined reasons for non-vaccination and sources of discouragement. By comparing attitudes across these two vaccine-preventable infections, the study seeks to inform tailored strategies to improve vaccination coverage and strengthen public trust in immunization programs in Poland. Material and methods Study design and data collection We conducted a real-world multicenter observational study including consecutive unvaccinated pediatric patients hospitalized with influenza or COVID-19 between September and December 2025 in pediatric wards in Poland. The study was conducted after obtaining a positive opinion and approval of the Bioethics Committee of the Jan Kochanowski University in Kielce (resolution no. 16/2025). Patient consent was waived due to the retrospective design of the study. All data were retrieved retrospectively from medical documentation and included: age, sex, comorbidities, hospitalization length, and clinical data characterizing disease severity, including development of pneumonia, need for antibiotic treatment due to bacterial coinfections, and C-reactive protein (CRP) concentrations exceeding 30 mg/L (a pragmatic cut-off used in pediatric studies to identify higher inflammatory burden24,25). The inclusion criteria were being Polish and having a child hospitalized with influenza or COVID-19 who was eligible for, but had not received, the respective vaccine. As part of a routine interview collected for medical records, parents were asked about the reasons they did not vaccinate their children against influenza or COVID-19, and whether the opinions of others, institutions, the media, or the internet influenced their decision. A standard set of questions regarding vaccinations answered by parents of sick children during their hospitalization, shortly after diagnosis, is presented in the supplementary material. They were also surveyed on whether they regretted the decision not to vaccinate their child against influenza or COVID-19, intend to vaccinate their child against influenza or COVID-19 in the subsequent epidemic season, wish to receive a reminder about the possibility of vaccinating their children against influenza or COVID-19 in the subsequent epidemic season, and will encourage other parents to vaccinate their children against influenza or COVID-19. Statistical analyses Data were analyzed using Statistica version 15.0 (StatSoft Inc., USA). Differences in the distribution of demographic and clinical categorical variables, as well as responses to specific questions on parental attitudes toward vaccination, were assessed using Pearson’s chi-square (χ2) test or Fisher’s exact test if expectancy was below 5. Because continuous variables (age and length of hospitalization) did not meet the assumption of Gaussian distribution, between-group comparisons were performed using the nonparametric Mann – Whitney U test. To understand whether hospitalization of an unvaccinated child due to influenza or COVID-19 is an independent predictor of parental vaccination-related attitudes in vaccination perception, a set of multivariable logistic regression analyses was performed. Independent variables used for adjustment included: age >2 y, sex, hospitalization ≥5 d, pneumonia onset, CRP > 30 mg/L, and presence of comorbidities. A p-value of less than 0.05 was considered statistically significant in all analyses. Results The study included 72 children hospitalized with influenza and 63 with COVID-19. Children with COVID-19 were younger, while other demographic and clinical characteristics were broadly comparable (Table 1). Table 1.Demographic and clinical characteristics of unvaccinated children hospitalized with influenza or COVID-19 (n = 135).ParameterCOVID-19(n = 63)Influenza(n = 72)p-valueAge, mean ± SD (years)1.8 ± 3.55.1 ± 3.8<.00001Age >2 y, % (n)14 (9)72 (52)<.00001Sex, female/male, % (n)35 (22) / 65 (41)46 (33) / 54 (39).198Inhabited area, urban/rural, % (n)65 (41) / 35 (22)51 (37) / 49 (35).157Any comorbidity, % (n)44 (28)54 (40).198Multimorbidity (%/n)8 (5)4 (3).355Cardiovascular disease, % (n)10 (6)3 (2).980Cancer, % (n)3 (2)1 (1).482Renal disease, % (n)2 (1)4/3).387Neurological disease, % (n)10 (6)28 (20).007Asthma, % (n)0 (0)4 (3).101Allergy, % (n)5 (3)6 (4).835Hospitalization length mean ± SD (days)3.9 ± 1.94.4 ± 2.3.186Hospitalization ≥5 d, % (n)24 (15)35 (25).116Pneumonia, % (n)8 (5)14 (10).272CRP >30 mg/L, % (n)14 (9)37 (27).002Antibiotic use, % (n)22 (14)26 (14).574 Demographic and clinical characteristics of unvaccinated children hospitalized with influenza or COVID-19 (n = 135). When compared to parents of children hospitalized with COVID-19, parents in the influenza group reported significantly higher rates of regret over not vaccinating (23.8% vs. 62.5%), willingness to vaccinate the following season (15.9% vs. 58.3%), and intent to encourage other parents to vaccinate (36.5% vs. 66.7%). Interest in a vaccination reminder for the next season, although numerically higher in the influenza group (51.4% vs. 41.3%), did not differ significantly (Figure 1). Attitudes of parents of unvaccinated children hospitalized with COVID-19 (n = 63) or influenza (n = 72) toward vaccination. Assessed outcomes included regret about not vaccinating their child, willingness to vaccinate the child in the next season, intention to encourage other parents to vaccinate, and willingness to receive a vaccination reminder in the following season. Differences between the influenza and COVID-19 groups were analyzed using Pearson’s chi-square test. Reasons for non-vaccination differed by disease (Figure 2(A)). For COVID-19, concerns over vaccine safety (30.5%), effectiveness (25.0%), and unawareness of eligibility (22.3%) were the most frequently cited. For influenza, the main reasons were perceiving the disease as insignificant (26.4%), vaccination not being mandatory (15.3%), and unawareness of eligibility (11.1%). (A) Parental reasons for refusing vaccination against COVID-19 and influenza for their child. (B) Distribution of sources of influence cited by parents who reported that their decision not to vaccinate their child against COVID-19 or influenza was influenced by others. Data are presented as percentages within the respective groups. External sources influenced the decision of 30.2% (COVID-19) and 19.4% (influenza) of parents, primarily through online information. Family and friends had a minor role, and healthcare professionals were rarely cited (Figure 2(B)). Regret over not vaccinating against COVID-19 was associated with having a child with comorbidities and rural residence. Willingness to vaccinate next season was linked to longer hospital stays and higher CRP levels (>30 mg/L). Desire for a reminder was associated with younger child age and comorbidities. For influenza, development of pneumonia was associated with changes in all assessed vaccination attitudes (Tables 2, 3). As shown through multiple logistic regression, hospitalization of an unvaccinated child due to influenza was an independent predictor of parental regret over not vaccinating a child (OR = 5.5, 95%CI: 2.2–14.0), intention to encourage other parents to vaccinate (OR = 3.9, 95%CI: 1.6–9.7), and willingness to vaccinate next season (OR = 9.3, 95%CI: 3.3–26.7), but not a predictor of the wish to receive a vaccination reminder next season (OR = 1.7, 95%CI: 0.7–4.2) (Figure 3). Table 2.Association of parental vaccination attitudes with demographic and clinical characteristics of their unvaccinated children hospitalized with COVID-19 (n = 63). Regrets not vaccinating the childWill vaccinate in the nextseasonWill encourage other parentsto vaccinateWants vaccination reminder nextseason YesNo +Do not knowYesNo +Do not knowYesNo +Do not knowYesNo +Do not knowAgemean ± SD (years)1.3 ± 2.72.0 ± 3.81.6 ± 3.31.9 ± 3.61.6 ± 3.02.0 ± 3.81.2 ± 2.42.3 ± 2.9p = .482p = .367p = .971p = .003Sexmale (%)66.764.680.062.373.960.057.770.3p = .882p = .280p = .265p = .304Inhabited areaurban (%)46.770.850.067.965.570.053.973.0p = .04p = .285p = .280p = .118Any comorbidity(%)66.737.560.041.552.240.056.826.9p = .04p = .280p = .349p = .02Multimorbidity(%)6.78.36.78.38.77.510.83.9p = .835p = .835p = .8670.314Hospitalization length mean ± SD (days)4.1 ± 1.33.9 ± 2.04.8 ± 1.43.8 ± 1.93.9 ± 1.53.9 ± 2.14.1 ± 1.53.8 ± 2.1p = .363p = .02p = .4430.145Pneumonia(%)6.78.320.05.78.77.57.78.1p = .835p = .124p = .867p = .952CRP >30 mg/L(%)13.314.640.09.421.710.015.413.5p = .903p = .01p = .200p = .834Antibiotic use(%)20.022.930.020.821.722.519.224.3p = .812p = .531p = .944p = .630CRP – C-reactive protein; SD – standard deviation. Association of parental vaccination attitudes with demographic and clinical characteristics of their unvaccinated children hospitalized with COVID-19 (n = 63). CRP – C-reactive protein; SD – standard deviation. Table 3.Association of parental vaccination attitudes with demographic and clinical characteristics of their unvaccinated children hospitalized with influenza (n = 72). Regrets not vaccinating the childWill vaccinatein the nextseasonWill encourage other parentsto vaccinateWants vaccination reminder nextseason YesNo +Do not knowYesNo +Do not knowYesNo +Do not knowYesNo +Do not knowAgemean ± SD (years)5.3 ± 3.64.8 ± 4.05.0 ± 3.65.2 ± 4.05.2 ± 3.64.8 ± 4.05.0 ± 3.65.2 ± 4.0p = .490p = .954p = .398p = .839Sexmale (%)51.159.352.456.752.158.348.760.0p = .501p = .719p = .615p = .334Inhabited areaurban (%)46.659.352.450.045.962.552.450.0p = .388p = .692p = .281p = .692Any comorbidity(%)59.851.857.153.358.350.057.153.30.624p = .748p = .503p = .748Multimorbidity(%)7.42.24.83.34.24.24.83.3p = .296p = .762p = 1.0p = .762Hospitalization length mean±SD (days)4.6 ± 2.53.9 ± 1.94.5 ± 1.94.1 ± 2.84.5 ± 1.84.2 ± 3.14.5 ± 1.94.1 ± 2.8p = .158p = .07p = .04p = .129Pneumonia(%)20.03.721.43.318.84.221.43.3p = .03p = .02p = .04p = .01CRP > 30 mg/L(%)42.229.642.226.739.633.342.226.7p = .281p = .105p = .604p = .109Antibiotic use(%)31.118.533.316,731.316.733.316,7p = .241p = .107p = .174p = .107CRP – C-reactive protein; SD – standard deviation. Association of parental vaccination attitudes with demographic and clinical characteristics of their unvaccinated children hospitalized with influenza (n = 72). CRP – C-reactive protein; SD – standard deviation. Multivariable analysis of predictors of (A) parent regretting not vaccinating a hospitalized child, (B) parent encouraging others to vaccinate their children, (C) wishing to vaccinate a child in the next season, and (D) wishing to receive a vaccination reminder in the next season. P-values are reported only for variables that were significant independent predictors (with odds ratios and 95% confidence intervals highlighted in pink); for all other variables, p > .05. As shown, pediatric hospitalization due to influenza (compared to COVID-19) was an independent predictor of (A), (B), and (C). Discussion To the best of our knowledge, this is the first study to comparatively analyze parental attitudes toward vaccination in the immediate aftermath of a child’s hospitalization due to influenza or COVID-19. It shows that pediatric hospitalizations due to influenza were associated with substantially more favorable post-hospitalization parental vaccination attitudes than hospitalizations due to COVID-19. Parents in the influenza cohort reported significantly greater regret over not vaccinating their children, a higher willingness to vaccinate them in the future, and a stronger intent to encourage pediatric vaccination among other parents. Several interrelated factors, discussed below, may explain this disparity. Importantly, these differences were not solely explained by measured demographic or clinical factors, as multivariable analysis confirmed that influenza hospitalization independently predicted key pro-vaccination attitudes, underscoring the robustness of this association. First, the perceived preventability of the hospitalization likely differs between the two diseases. Influenza vaccines have been administered in pediatric groups for decades, also in Poland, with a well-established efficacy profile,26,27 potentially making parents view the hospitalization as a more direct consequence of a preventable omission. This interpretation is supported by our finding that influenza vaccine refusal was primarily driven by other reasons than concerns over vaccine safety or effectiveness. In contrast, during the study period, public discourse often highlighted breakthrough infections and the evolving effectiveness of COVID-19 vaccines against infection,28,29 which may have diluted the perceived link between non-vaccination and the severe outcome in the parents’ assessment.30 Consistently, parents who refused COVID-19 vaccination most frequently cited concerns about vaccine safety, vaccine effectiveness, and lack of awareness of vaccination eligibility, factors that reflect deeper mistrust and informational gaps rather than mere complacency. Second, pre-existing attitudes and the sociopolitical context of COVID-19 and influenza vaccination differ markedly. Influenza vaccination is generally a routinized, seasonal health behavior, whereas COVID-19 vaccination became highly politicized, with deeply entrenched hesitancy in some cohorts that a single severe pediatric case may not overcome. Furthermore, the pervasive exposure to misinformation, politicization, and conflicting narratives about COVID-19 may have created a more resilient form of hesitancy, less amenable to change, even following a severe health consequence. While our study did not directly measure the influence of politicization or misinformation on parental decision-making, these factors have been widely documented in prior research and may plausibly contribute to the observed persistence of hesitancy.31,32 The predominance of safety- and effectiveness-related concerns among COVID-19 vaccine refusers suggests that hospitalization alone may be insufficient to counteract risk amplification driven by misinformation and uncertainty surrounding newer vaccines. Third, influenza is frequently misperceived by adult Poles as a benign illness akin to the common cold, contributing to widespread complacency and chronically low vaccination coverage, which remains among the lowest in the European Union.28 Having a child hospitalized due to this disease may therefore act as a “teachable moment,” delivering an undeniable and personal corrective experience, elevating the perceived seriousness and preventability of influenza. Although the cross-sectional design of our study does not allow inference about within-person attitudinal change before and after hospitalization, this interpretation is consistent with qualitative findings from parents of children hospitalized with influenza in Australia, who reported increased awareness of disease severity and greater intention to vaccinate following hospitalization, despite ongoing reservations regarding vaccine necessity and safety.33 In our study, this effect is further contextualized by the observation that some parents cited their child’s chronic illness or recurrent infections as reasons to forgo influenza vaccination, indicating persistent misconceptions about vaccine contraindications and safety in medically vulnerable children – precisely the group that stands to benefit most from immunization. Conversely, for COVID-19, the pervasive public awareness of its potential severity from the outset of the pandemic means a child’s hospitalization, while traumatic, may not provide the same cognitive shock regarding disease risk. Instead, the event may be interpreted through pre-existing, politicized frameworks of vaccine hesitancy, where the focus may remain on perceived vaccine risks, concerns over vaccine effectiveness, and conspiracy-driven beliefs on COVID-19 and its pandemic34,35 rather than on a newfound personal understanding of the disease’s threat. Such an effect was previously reported in Polish adults hospitalized with COVID-19, among whom one-third were still opposed to or unsure about vaccination, though this decreased with disease severity.32 Our research further demonstrates that parental vaccination-related attitudes were not uniform but were shaped by specific demographic and clinical characteristics of the child and family. In the COVID-19 cohort, regret over not vaccinating was significantly more common among parents of children with comorbidities and among those residing in rural areas, suggesting that perceived vulnerability of the child and potentially reduced access to preventive health messaging may intensify retrospective appraisal following severe illness. Willingness to vaccinate the child in the next season was associated with markers of disease severity, including longer hospital stays and elevated inflammatory markers (CRP > 30 mg/L), suggesting that more severe clinical courses may strengthen perceived vaccination benefits. Additionally, the desire to receive a vaccination reminder was more frequent among parents of younger children and those with comorbidities, underscoring the role of perceived risk and parental responsibility in shaping openness to preventive interventions. In turn, in the influenza cohort, the development of pneumonia emerged as a particularly salient factor, being associated with changes across all assessed vaccination-related attitudes. Pneumonia represents a well-recognized severe complication of influenza,36–38 often perceived by parents as a life-threatening escalation rather than a routine manifestation of viral illness. Its occurrence may therefore markedly heighten parental awareness of influenza’s potential severity and disrupt prevailing perceptions of the disease as mild or self-limiting. This finding reinforces the notion that hospitalization severity, especially when complications arise, is a powerful catalyst for reassessing prior vaccine decisions. These distinct explanatory pathways lead to divergent implications for vaccination policy and clinical communication, which must be tailored to address the specific nature of hesitancy encountered for each disease. For influenza, interventions should prioritize correcting disease trivialization and clarifying false contraindications, particularly among parents of children with chronic or recurrent illnesses. For COVID-19, strategies must more directly address safety concerns, vaccine effectiveness, and gaps in awareness of vaccination eligibility, ideally through trusted healthcare professionals and evidence-based communication. In this context, the development of combination vaccines targeting more than one respiratory virus (e.g., influenza and SARS-CoV-2) may represent a promising complementary strategy.39,40 Such approaches could simplify immunization schedules, reduce logistical barriers, and potentially improve uptake among hesitant parents by framing vaccination as a single, routine preventive action rather than multiple separate decisions. However, their real-world impact will depend on addressing the same underlying concerns regarding safety, effectiveness, and trust identified in our study. Notably, despite generally more hesitant attitudes among parents of children hospitalized for COVID-19, 41% of these parents indicated a desire to receive a vaccine reminder for the next season, compared with 51% in the influenza group. This finding suggests that even when comprehensive attitudinal change is limited, the experience of a severe pediatric illness can create an opportunity for engagement, wherein parents become more receptive to structured, low-barrier interventions. However, as our study assessed stated intentions rather than observed behaviors, it remains uncertain to what extent this receptiveness translates into actual vaccine uptake. Evidence suggests that vaccine reminders, particularly when personalized and delivered in advance of periods of elevated seasonal risk, can function as an effective behavioral nudge, also in the pediatric context.41,42 In Poland, the increasing adoption of the nationally implemented mobile health application (mojeIKP), introduced by the Ministry of Health, represents a substantial yet underutilized opportunity for public health intervention. Official data indicate that by the end of 2025, over 4 million individuals in Poland were using this platform. The application integrates a range of healthcare services and supports push notifications,43 which were shown to have a positive impact on pediatric vaccine uptake compared to non-digital interventions.44 Accordingly, its potential to deliver seasonal vaccination reminders (a feature not currently employed) appears considerable, as even vaccine-hesitant parents wish to receive reminders about the availability of future vaccines. This is especially significant in light of our finding that informational barriers and awareness deficits remain prominent reasons for vaccine refusal. Therefore, we argue that strategically leveraging this tool may potentially enhance the prevention of respiratory infections among the pediatric population. Among parents who reported being influenced by others, the information found on the internet emerged as the most frequently cited source for both COVID-19 and influenza vaccination refusals. Online environments are known to disproportionately amplify uncertainty, misinformation, and emotionally charged narratives surrounding vaccines, and may be deliberately used for such a purpose.45–47 Medical doctors, other healthcare workers, family, and friends played a comparatively minor role in the refusal of pediatric COVID-19 and influenza vaccinations. These observations point to a critical and growing digital information gap in public health. As parents are increasingly prolific users of online resources for health information,48 traditional, trust-based pillars of guidance, i.e., clinicians and personal networks, are being overshadowed by a digital ecosystem that often privileges algorithmic engagement over factual accuracy, exposing parents to a skewed risk-benefit analysis. Consequently, our findings underscore an urgent need for proactive digital health literacy interventions, as evidence shows such tools can improve parental health knowledge.49 Public health communication must evolve by meeting parents on the digital platforms, creating engaging, attractive health-specific content that preemptively addresses common concerns and counters misinformation. Furthermore, equipping healthcare providers with the skills to effectively discuss and deconstruct online vaccine misinformation during clinical consultations is essential to rebuilding their influence as primary, trusted sources of evidence-based guidance.50 Study limitations should be stressed. First, the sample included only unvaccinated children, precluding comparisons with parents of vaccinated children and limiting the ability to fully assess determinants of vaccine acceptance. Second, some subsets of individuals were under-represented, e.g., children with particular comorbidities. Third, social desirability bias may have influenced parental responses, particularly regarding intentions to vaccinate or encourage others. Fourth, not all declarations given in the study by parents may be reflected in actual future decisions. Fifth, while we explored associations with demographic and clinical factors, the observational design does not allow causal inferences, and unmeasured confounders, such as socioeconomic status or parental education, may have influenced attitudes and decision-making. Importantly, the study assessed parental attitudes only after hospitalization and did not include pre-hospitalization baseline measurements; therefore, observed differences between groups cannot be interpreted as within-person changes attributable to hospitalization. Finally, the external validity of our findings may be limited. The study was conducted in Poland over a relatively short period (September to December 2025), within a specific sociopolitical and public health context that has shaped both COVID-19 and influenza vaccination attitudes. Consequently, the observed patterns of hesitancy and attitudinal change may differ in settings with higher baseline vaccine uptake, different healthcare systems, or alternative policy and communication environments and should therefore be interpreted as context-specific and hypothesis-generating rather than universally generalizable. Conclusions This multicenter observational study shows that pediatric hospitalization for vaccine-preventable respiratory infections can influence parental vaccination attitudes, but with markedly different effects for influenza versus COVID-19. These differences persisted after accounting for potential confounders, indicating that the type of infection itself plays an independent role in shaping parental responses within the studied sociocultural context. Influenza hospitalization, especially when complicated by pneumonia, was consistently associated with greater parental regret over non-vaccination, increased willingness to vaccinate in future seasons, and stronger advocacy for vaccination, suggesting a potentially more reliable “teachable moment.” In contrast, parental responses following pediatric COVID-19 hospitalization were more variable and strongly shaped by disease severity, child age, comorbidities, and sociodemographic factors, with persistent concerns about vaccine safety, effectiveness, and eligibility. These findings suggest leveraging post-hospitalization encounters for tailored, disease-specific counseling, prioritizing families of children with comorbidities or severe illness, implementing low-barrier interventions such as personalized reminders via digital health platforms, and addressing online misinformation by strengthening digital health literacy and reinforcing clinicians as trusted vaccine information sources. Future studies are needed to determine whether interventions implemented in this context would translate into sustained behavioral change and improved vaccination coverage. Supplementary Material SM.docx Funding Statement The author(s) reported there is no funding associated with the work featured in this article. The article processing charges were covered by statutory funds from the Department of Environmental Medicine, Poznan University of Medical Sciences, Poland. Disclosure statement P. Rzymski reports grants, advisory, consultation, and lecture honoraria from Pfizer, advisory fees from Moderna, and lecture fees from Sanofi. R. Flisiak reports advisory honoraria from Pfizer. D. Zarębska-Michaluk reports advisory honoraria from Pfizer. The other authors report no conflict of interest. Data availability statement The data that support the findings of this study are available from the corresponding author upon reasonable request. Ethics statement The study was conducted after obtaining a positive opinion and approval of the Bioethics Committee of the Jan Kochanowski University in Kielce (resolution no. 16/2025). Patient consent was waived due to the retrospective design of the study. Supplemental material Supplemental data for this article can be accessed online at https://doi.org/10.1080/21645515.2026.2684310 References Associated Data Supplementary Materials SM.docx Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.